Titan Health appoints Natalia Casanovas as CEO, reinforcing its 2026 growth strategy and commitment to execution, ...
SHENZHEN, GUANGDONG, CHINA, January 9, 2026 /EINPresswire.com/ -- Shenzhen Senghor Sea & Air Logistics Co., Ltd., a ...
Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high ...
Denali Therapeutics announced that results from its open-label Phase 1/2 trial of tividenofusp alfa for Hunter syndrome were published in the January 1, 2026 issue of The New England Journal of ...
Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in ...
What Changed in the Alkermes Price Target Alkermes just saw its fair value estimate nudged from about US$43.88 to US$43.81 per share, a very small trim that reflects only a modest reset in assumptions ...
XRP flips BNB to third place with $13.6M ETF inflows fueling breakout rally. Technical charts signal potential move toward $2 ...
At their respective “imperial phases,” Mariah Carey and the Eraserheads released Christmas albums that remain iconic to this day ...
A combination of one "offense" ETF, one "defense" ETF, and a method to tactically allocate among them could help simplify ...
Bitcoin whale wallets acquire 2,509 BTC as macro cycle charts question bull timing and Bitcoin dominance nears resistance.
Billboard and YouTube are closing out 2025 with a feud, of sorts, centered on the charts value of ad-supported streams. As always, we’re here to break down the key takeaways from this latest industry ...
The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results